GlaxoSmithKline PLC at Morgan Stanley ESG Insights Conference (Virtual) Transcript
It gives me great pleasure to introduce Phil Thomson, something I haven't caught up with for a while. So Phil thanks for joining us. Phil is the President of Global Affairs at GSK. So he's going to provide us with a presentation just to kick off this session, and then we're going to move into Q&A.
So if you have a question, you can send them through the chat box to me and also (inaudible) together and -- for Phil to go through. But otherwise, Phil, over to you. Thanks so much for joining us. It's great to see you again. Let's kick off with the presentation, then we'll move to Q&A.
Great. Thanks, Mark. It's great to be here virtually with you. And as you say, caught up for a long time, but it's great to do so. So thank you.
So I thought I'd start, as you said, with a few slides, just to orientate everybody on GSK's approach to ESG. And I'm hoping that people can see the slides because I can't.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
